Cell & Gene Therapy 2018


On 3 & 4 December 2018, Kuala Lumpur in Malaysia, will host the BioTech Pharma Summit: Cell & Gene Therapy 2018 conference. This year’s event is bringing together academia and industry to showcase several new technologies emerging in the field of cell and gene therapy. The BioTech Pharma Summit: Cell & Gene Therapy 2018 is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell & Gene Therapy area.

Uncover the future of market access and commercialization approaches for innovative cell & gene therapies through a C-suite level panel discussion at the Cell & Gene Therapy 2018

Cell and Gene therapies are poised to revolutionize medicine and dramatically change the lives of the patients they will treat. However, there is much uncertainty surrounding the long-term outcomes of these therapies and whether the clinical performance will reach expectations based on the evidence presented at launch. This, alongside the high costs of cell and gene therapies, present challenges for the market access, as well as pricing and reimbursement of these innovative treatments

Hear scientist and researcher views around partnering to understand perspectives around value enhancing development, pricing, and distribution of therapies

This two-day Cell & Gene Therapy 2018 will address key issues concerning cell therapy & gene therapy research in the broader context of cellular and genetic disorder. Organized around daily themes, this conference focuses on moving from present knowledge to future solutions thus imparting the knowledge growth and awareness among people.


  • Perspectives on adjustments and Bio-Quality of Cell & Gene Therapy Bioprocessing
  • Future Enhancements of Manufacturing Technologies
  • Preclinical Development of Novel Technologies
  • Identify the Opportunities and Challenges in Advanced Therapy Manufacturing Process
  • Regulatory insight on ATMP Development
  • Future Vision of Gene Therapy Production
  • Cell, Gene and Immunotherapy Manufacturing
  • Automation and Cold Chain
  • Funding and Regulatory Challenges
  • Cell, Gene and Immunotherapy USP, DSP, PAT and Analytics
  • Preclinical Strategies for Cell, Gene and Immunotherapies
  • Clinical Development for Cell, Gene and Immunotherapies
  • Emerging Cell Therapy Treatments
  • Analytical Testing and Quality System
  • Product Development and Commercialization


The BioTech Pharma Summit (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors including:

  • Cell Therapy Research
  • Manufacturing Innovation
  • Global Medical Affairs
  • CMC
  • Health economics
  • Strategic Marketing
  • Regulatory Affairs
  • Regenerative Medicine
  • Advanced Therapy Production
  • Gene Therapy Development
  • Clinical Platform Development
  • Cellular Therapy Immuno-Oncology
  • Manufacturing and R&D
  • Quality Control
  • GMP
  • Global Pricing and Market Access
  • Cell & Tissue Therapy
  • Biotechnologists
  • Immunologists
  • Pricing &Reimbursement
  • Payer Strategy
  • Payer Marketing
  • National Account Managers
  • Advanced Therapy Production



Basic Package
Buy Ticket

Access to all Sessions

Access to all Networking Sessions

Cocktail Reception Included

Premium Package
Buy Ticket

Unique one-on-one meetings

Airport pick-up/drop-off

2 nights at the Hotel Venue

Basic Exhibition Package
Buy Ticket

3m2 exhibition space

1 Complementary ticket

25% discount for extra ticket

Premium Exhibition Package
Buy Ticket

6m2 exhibition space

1 Complementary ticket

2 nights at the Hotel Venue